251 related articles for article (PubMed ID: 15146241)
1. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
Dwyer KM; Robson SC; Nandurkar HH; Campbell DJ; Gock H; Murray-Segal LJ; Fisicaro N; Mysore TB; Kaczmarek E; Cowan PJ; d'Apice AJ
J Clin Invest; 2004 May; 113(10):1440-6. PubMed ID: 15146241
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
3. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
4. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
[TBL] [Abstract][Full Text] [Related]
5. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
6. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.
Roberts V; Campbell DJ; Lu B; Chia J; Cowan PJ; Dwyer KM
Transplantation; 2017 Jul; 101(7):e194-e204. PubMed ID: 28198766
[TBL] [Abstract][Full Text] [Related]
7. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
8. Ischemic Cerebroprotection Conferred by Myeloid Lineage-Restricted or Global CD39 Transgene Expression.
Baek AE; Sutton NR; Petrovic-Djergovic D; Liao H; Ray JJ; Park J; Kanthi Y; Pinsky DJ
Circulation; 2017 Jun; 135(24):2389-2402. PubMed ID: 28377485
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.
Pinsky DJ; Broekman MJ; Peschon JJ; Stocking KL; Fujita T; Ramasamy R; Connolly ES; Huang J; Kiss S; Zhang Y; Choudhri TF; McTaggart RA; Liao H; Drosopoulos JH; Price VL; Marcus AJ; Maliszewski CR
J Clin Invest; 2002 Apr; 109(8):1031-40. PubMed ID: 11956240
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
[TBL] [Abstract][Full Text] [Related]
11. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.
Mizumoto N; Kumamoto T; Robson SC; Sévigny J; Matsue H; Enjyoji K; Takashima A
Nat Med; 2002 Apr; 8(4):358-65. PubMed ID: 11927941
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
[TBL] [Abstract][Full Text] [Related]
13. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.
Atkinson B; Dwyer K; Enjyoji K; Robson SC
Blood Cells Mol Dis; 2006; 36(2):217-22. PubMed ID: 16476557
[TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
[TBL] [Abstract][Full Text] [Related]
15. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
16. The transgenic expression of human CD39 on murine islets inhibits clotting of human blood.
Dwyer KM; Mysore TB; Crikis S; Robson SC; Nandurkar H; Cowan PJ; D'Apice AJ
Transplantation; 2006 Aug; 82(3):428-32. PubMed ID: 16906044
[TBL] [Abstract][Full Text] [Related]
17. Production of heterozygous alpha 1,3-galactosyltransferase (GGTA1) knock-out transgenic miniature pigs expressing human CD39.
Choi K; Shim J; Ko N; Eom H; Kim J; Lee JW; Jin DI; Kim H
Transgenic Res; 2017 Apr; 26(2):209-224. PubMed ID: 27830476
[TBL] [Abstract][Full Text] [Related]
18. Disordered cellular migration and angiogenesis in cd39-null mice.
Goepfert C; Sundberg C; Sévigny J; Enjyoji K; Hoshi T; Csizmadia E; Robson S
Circulation; 2001 Dec; 104(25):3109-15. PubMed ID: 11748109
[TBL] [Abstract][Full Text] [Related]
19. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury.
Crikis S; Lu B; Murray-Segal LM; Selan C; Robson SC; D'Apice AJ; Nandurkar HH; Cowan PJ; Dwyer KM
Am J Transplant; 2010 Dec; 10(12):2586-95. PubMed ID: 20840479
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
Gayle RB; Maliszewski CR; Gimpel SD; Schoenborn MA; Caspary RG; Richards C; Brasel K; Price V; Drosopoulos JH; Islam N; Alyonycheva TN; Broekman MJ; Marcus AJ
J Clin Invest; 1998 May; 101(9):1851-9. PubMed ID: 9576748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]